ICD-10-CM Billable Code

M11.11

Familial chondrocalcinosis, shoulder

Clinical Classification Guidelines

Medical Intelligence & Overview

Familial chondrocalcinosis, also known as calcium pyrophosphate dihydrate (CPPD) crystal deposition disease, is a hereditary condition characterized by the accumulation of calcium pyrophosphate crystals within the cartilage of joints. When this condition affects the shoulder, it can lead to pain, swelling, and reduced mobility in this joint. This guide provides insight into the causes, symptoms, diagnosis, and treatment options for familial chondrocalcinosis of the shoulder.

Causes & Symptoms

Clinical Causes: Genetic factors: Familial chondrocalcinosis is inherited, often following an autosomal dominant pattern, meaning only one copy of the altered gene can cause the disorder. Metabolic abnormalities: Conditions like hyperparathyroidism, hemochromatosis, and hypophosphatasia can predispose individuals to crystal deposits. Aging: The risk of crystal deposition increases with age, even in the absence of hereditary factors.

Key Symptoms: Shoulder pain that may be sudden or gradually worsening Swelling and inflammation around the shoulder joint Stiffness and limited range of motion in the shoulder Tenderness upon touching the affected area Possible crepitus or grinding sensation during shoulder movement Recurrent episodes of acute joint inflammation

Diagnostic & Treatment

Diagnosis Path: To confirm familial chondrocalcinosis of the shoulder, healthcare providers typically perform a combination of assessments:

Treatment Protocols: While there is no cure for familial chondrocalcinosis, management aims to alleviate symptoms and improve joint function:

Reimbursement claims with a date of service on or after October 1, 2015 require the use of ICD-10-CM codes.

Clinical Advice & FAQs

Billing Guidance

Is M11.11 a billable ICD-10 code?
Yes, M11.11 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.

Documentation

How do I report M11.11?
Clinical documentation must specify the nature of Familial chondrocalcinosis, shoulder and any associated comorbidities for accurate reporting.

Cite this Clinical Reference